CHOROIDAL NEOVASCULARIZATION SECONDARY TO SORSBY FUNDUS DYSTROPHY TREATED WITH INTRAVITREAL BEVACIZUMAB


    loading  Checking for direct PDF access through Ovid

Abstract

PurposeTo report a case of extrafoveal choroidal neovascularization secondary to Sorsby fundus dystrophy that maintained 20/20 visual acuity over 14 months with intravitreal bevacizumab therapy.MethodsInterventional case report of as-needed treatment with intravitreal bevacizumab of a 38-year-old lady with choroidal neovascularization from Sorsby fundus dystrophy.ResultsThree injections of intravitreal bevacizumab were given over 14.5 months, maintaining visual acuity at 20/20.ConclusionIntravitreal bevacizumab therapy appears to maintain vision in patients with choroidal neovascularization from Sorsby fundus dystrophy.

    loading  Loading Related Articles